News Opinion Fellow Talk What I Am Most Looking Forward to at TCT 2019 Mahesh V. Madhavan, MD September 18, 2019
News Opinion Fellow Talk Pursuing Training in Structural Heart Interventions: Q&A With Mario Gössl, MD Yashasvi Chugh, MD August 05, 2019
News Features Structural Heart Hype: As Fellowship Programs Mushroom, Who’s Keeping Tabs on Quality and Numbers? Yael L. Maxwell August 02, 2019
News Conference News SCAI 2019 TAVR Operators: Can One Do It All or Are Two Still Justified? Yael L. Maxwell June 04, 2019
News Conference News EuroPCR 2019 Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements Shelley Wood May 16, 2019
News Conference News CRT 2019 Adverse Events Reports for Guide Extension Catheter Should Spur Cautious Use Yael L. Maxwell March 05, 2019
News Conference News STS 2019 No ‘July Effect’ Observed in Cardiac Surgery Yael L. Maxwell February 05, 2019
News Daily News Better TAVR Outcomes With More Experienced Operators: New York Database Michael O'Riordan December 12, 2018
News Opinion Fellow Talk Why I Chose a Career in Interventional Cardiology Lowie Van Assche, MD September 05, 2018
News Daily News ‘We Have to Go to Them’: New Global Initiative for Treating Rheumatic Heart Disease Michael O'Riordan August 06, 2018
News Conference News EuroPCR 2018 European Consortium Seeks to Increase the Role of Cardiologists in Acute Ischemic Stroke Care Yael L. Maxwell June 05, 2018
News Conference News TCT 2017 3-D Printing Opportunities Emerge for Cardiologists, Hospitals, and Device Companies Alike Yael L. Maxwell October 31, 2017
News Features A Heart to Hold: 3-D Printers Add New Dimension to the Treatment of Structural Cardiac Disease Yael L. Maxwell August 02, 2017
News Conference News TVT 2017 Volume Underload? More TAVRs Done, the Better the Operator Outcomes, Yet Many Patients Go Untreated Michael O'Riordan June 16, 2017
News Conference News EuroPCR 2017 EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40 Shelley Wood May 12, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017